1.Value of liver and spleen stiffness measured by two-dimensional shear wave elastography in diagnosing the severity of portal hypertension
Min WANG ; Guanhua ZHANG ; Lijuan FENG ; Yuhong SUO ; Fuliang HE ; Xiangdong HU ; Min LI ; Yu WANG
Journal of Clinical Hepatology 2026;42(5):1075-1082
ObjectiveTo investigate the value of liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) measured by two-dimensional shear wave elastography (2D-SWE) in the diagnosis of severe portal hypertension (SPH) and high-risk varices (HRV), and to provide a basis for noninvasive assessment of portal hypertension. MethodsA prospective study was conducted among 78 patients with cirrhotic portal hypertension who were treated in Liver Research Center of Beijing Friendship Hospital, Capital Medical University, from December 2019 to April 2023. According to hepatic venous pressure gradient (HVPG), the patients were divided into 6 mmHg≤HVPG<12 mmHg group, 12 mmHg≤HVPG<20 mmHg group, and HVPG ≥20 mmHg group. All patients underwent gastroscopy and 2D-SWE within 1 week after HVPG measurement, and SWE-LSM and SWE-SSM measured by 2D-SWE were recorded. A one-way analysis of variance or the Kruskal-Wallis H test was used for comparison of continuous data between multiple groups, and the chi-square test or the Fisher’s exact test was used for comparison of categorical data between groups. With HVPG and gastroscopy findings as the gold standard, the receiver operating characteristic (ROC) curve was plotted and the area under the ROC curve (AUC) was calculated to evaluate diagnostic performance, while the DeLong test was used for comparison of AUC. The Pearson or Spearman correlation analysis was used to investigate the correlation between variables, and the linear regression analysis and the Logistic regression analysis were used to investigate the influencing factors for HVPG and HRV. ResultsThe mean HVPG was 18.1±6.4 mmHg for the patients enrolled in this study, and HRV was observed in 62 patients (79.5%). Both SWE-LSM and SWE-SSM were significantly positively correlated with HVPG (r=0.413 and 0.633, both P<0.001), with an AUC of 0.812 and 0.902, respectively, in the diagnosis of HVPG≥12 mmHg and an AUC of 0.804 and 0.789, respectively, in the diagnosis of HVPG≥20 mmHg (all P>0.05). The multivariate linear regression analysis showed that SWE-SSM was an independent influencing factor for HVPG (β=0.17, P<0.001). In the diagnosis of HRV, only SWE-SSM showed a significant positive correlation with HRV (r=0.432, P<0.001), with a better diagnostic performance than SWE-LSM in terms of AUC (0.808 vs 0.642, Z=2.775, P=0.006). The multivariate Logistic regression analysis showed that platelet count was an independent influencing factor for HRV (odds ratio=0.97, P=0.014). ConclusionSWE-SSM is closely correlated with both HVPG and HRV, showing a good performance in the diagnosis of SPH and HRV, and therefore, it is expected to become an effective noninvasive tool for assessing portal hypertension.
2.Development and clinical translation of intelligent assistive devices for minimally invasive thoracic surgery
Jiwei ZHU ; Honghai MA ; Chunlin ZHOU ; Zhehao HE ; Tong SHEN ; Haojie YU ; Luming WANG ; Jian HU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(07):1013-1022
Although video-assisted thoracoscopic surgery (VATS) offers clear advantages, including minimal trauma and rapid recovery, stable intraoperative visualization still depends heavily on the camera assistant. Traditional manual endoscope holding is therefore susceptible to several limitations, including image instability, assistant fatigue, and poor coordination with the primary surgeon. Operating in complex and confined anatomical spaces with a rigid thoracoscope further increases the demands on hand-eye coordination. Thoracoscopic camera-holding technology has progressively evolved from passive support systems to active camera holders and robot-assisted thoracic surgery (RATS) platforms, and is now advancing toward artificial intelligence-driven tracking and intelligent control. Based on this, a series of devices, including multifunctional intelligent assistant arms and active camera-holding arms for thoracic surgery, have been developed and have attracted increasing attention. This article reviews the development of intelligent camera-holding assistant arms and discusses related advances and future directions in the field.
3.Retrospective study on transfusion strategies and red blood cell transfusion thresholds in orthopedic surgery
Zijuan LIU ; Liu HE ; Yuwei HU ; Yunhong YU ; Ling LI
Chinese Journal of Blood Transfusion 2026;39(7):874-880
Objective: To evaluate the clinical value of a restrictive red blood cell transfusion strategy in orthopedic patients by retrospectively analyzing the current transfusion practices and comparing postoperative outcomes across different transfusion thresholds. Methods: Clinical data of patients who underwent orthopedic surgery and received blood transfusions at a single hospital from 2015 to 2020 were retrospectively collected for descriptive analysis. Patients were then stratified into two groups based on pre-transfusion hemoglobin (Hb) thresholds:70-79 g/L group (n=92) and 80-89 g/L group (n=120), and their data were compared in terms of postoperative hematological parameters, functional recovery, transfusion volume, and adverse events. Results: Among patients receiving orthopedic surgery and transfusion, elderly females accounted for a relatively high proportion. Transfusion requirements varied significantly across different surgical types, with marked differences in red blood cell transfusion volumes (P<0.001). Revision arthroplasty and spinal surgery had higher median volumes (3.5-3.0 U). Subgroup analysis revealed that the 70-79 g/L group had significantly higher postoperative D-dimer and creatinine levels than the 80-89 g/L group (Z=-2.035, P=0.042; Z=-2.523, P=0.012). The pre-transfusion pain score was also significantly higher in the 70-79 g/L group (Z=-2.828, P=0.005), but no significant difference was observed in post-transfusion pain scores between the two groups (P>0.05). Conclusion: This study did not observe significant differences in postoperative adverse events, functional recovery, or transfusion volume-related indicators between the two transfusion thresholds. These findings provide clinical reference data for future studies on the safety and applicability of restrictive transfusion strategies in the orthopedic perioperative setting.
4.Application of CRISPR/Cas System in Precision Medicine for Triple-negative Breast Cancer
Hui-Ling LIN ; Yu-Xin OUYANG ; Wan-Ying TANG ; Mi HU ; Mao PENG ; Ping-Ping HE ; Xin-Ping OUYANG
Progress in Biochemistry and Biophysics 2025;52(2):279-289
Triple-negative breast cancer (TNBC) represents a distinctive subtype, characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). Due to its high inter-tumor and intra-tumor heterogeneity, TNBC poses significant chanllenges for personalized diagnosis and treatment. The advant of clustered regular interspaced short palindromic repeats (CRISPR) technology has profoundly enhanced our understanding of the structure and function of the TNBC genome, providing a powerful tool for investigating the occurrence and development of diseases. This review focuses on the application of CRISPR/Cas technology in the personalized diagnosis and treatment of TNBC. We begin by discussing the unique attributes of TNBC and the limitations of current diagnostic and treatment approaches: conventional diagnostic methods provide limited insights into TNBC, while traditional chemotherapy drugs are often associated with low efficacy and severe side effects. The CRISPR/Cas system, which activates Cas enzymes through complementary guide RNAs (gRNAs) to selectively degrade specific nucleic acids, has emerged as a robust tool for TNBC research. This technology enables precise gene editing, allowing for a deeper understanding of TNBC heterogeneity by marking and tracking diverse cell clones. Additionally, CRISPR facilitates high-throughput screening to promptly identify genes involved in TNBC growth, metastasis, and drug resistance, thus revealing new therapeutic targets and strategies. In TNBC diagnostics, CRISPR/Cas was applied to develop molecular diagnostic systems based on Cas9, Cas12, and Cas13, each employing distinct detection principles. These systems can sensitively and specifically detect a variety of TNBC biomarkers, including cell-specific DNA/RNA and circulating tumor DNA (ctDNA). In the realm of precision therapy, CRISPR/Cas has been utilized to identify key genes implicated in TNBC progression and treatment resistance. CRISPR-based screening has uncovered potential therapeutic targets, while its gene-editing capabilities have facilitated the development of combination therapies with traditional chemotherapy drugs, enhancing their efficacy. Despite its promise, the clinical translation of CRISPR/Cas technology remains in its early stages. Several clinical trials are underway to assess its safety and efficacy in the treatment of various genetic diseases and cancers. Challenges such as off-target effects, editing efficiency, and delivery methods remain to be addressed. The integration of CRISPR/Cas with other technologies, such as 3D cell culture systems, human induced pluripotent stem cells (hiPSCs), and artificial intelligence (AI), is expected to further advance precision medicine for TNBC. These technological convergences can offer deeper insights into disease mechanisms and facilitate the development of personalized treatment strategies. In conclusion, the CRISPR/Cas system holds immense potential in the precise diagnosis and treatment of TNBC. As the technology progresses and becomes more costs-effective, its clinical relevance will grow, and the translation of CRISPR/Cas system data into clinical applications will pave the way for optimal diagnosis and treatment strategies for TNBC patients. However, technical hurdles and ethical considerations require ongoing research and regulation to ensure safety and efficacy.
5.Processing technology of calcined Magnetitum based on concept of QbD and its XRD characteristic spectra.
De-Wen ZENG ; Jing-Wei ZHOU ; Tian-Xing HE ; Yu-Mei CHEN ; Huan-Huan XU ; Jian FENG ; Yue YANG ; Xin CHEN ; Jia-Liang ZOU ; Lin CHEN ; Hong-Ping CHEN ; Shi-Lin CHEN ; Yuan HU ; You-Ping LIU
China Journal of Chinese Materia Medica 2025;50(9):2391-2403
Guided by the concept of quality by design(QbD), this study optimizes the calcination and quenching process of calcined Magnetitum and establishes the XRD characteristic spectra of calcined Magnetitum, providing a scientific basis for the formulation of quality standards. Based on the processing methods and quality requirements of Magnetitum in the Chinese Pharmacopoeia, the critical process parameters(CPPs) identified were calcination temperature, calcination time, particle size, laying thickness, and the number of vinegar quenching cycles. The critical quality attributes(CQAs) included Fe mass fraction, Fe~(2+) dissolution, and surface color. The weight coefficients were determined by combining Analytic Hierarchy Process(AHP) and the criteria importance though intercrieria correlation(CRITIC) method, and the calcination process was optimized using orthogonal experimentation. Surface color was selected as a CQA, and based on the principle of color value, the surface color of calcined Magnetitum was objectively quantified. The vinegar quenching process was then optimized to determine the best processing conditions. X-ray diffraction(XRD) was used to establish the characteristic spectra of calcined Magnetitum, and methods such as similarity evaluation, cluster analysis, and orthogonal partial least squares-discriminant analysis(OPLS-DA) were used to evaluate the quality of the spectra. The optimized calcined Magnetitum preparation process was found to be calcination at 750 ℃ for 1 h, with a laying thickness of 4 cm, a particle size of 0.4-0.8 cm, and one vinegar quenching cycle(Magnetitum-vinegar ratio 10∶3), which was stable and feasible. The XRD characteristic spectra analysis method, featuring 9 common peaks as fingerprint information, was established. The average correlation coefficient ranged from 0.839 5-0.988 1, and the average angle cosine ranged from 0.914 4 to 0.995 6, indicating good similarity. Cluster analysis results showed that Magnetitum and calcined Magnetitum could be grouped together, with similar compositions. OPLS-DA discriminant analysis identified three key characteristic peaks, with Fe_2O_3 being the distinguishing component between the two. The final optimized processing method is stable and feasible, and the XRD characteristic spectra of calcined Magnetitum was initially established, providing a reference for subsequent quality control and the formulation of quality standards for calcined Magnetitum.
X-Ray Diffraction/methods*
;
Drugs, Chinese Herbal/chemistry*
;
Quality Control
;
Particle Size
6.Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions.
Li LIU ; Lei ZHANG ; Wei-An YUAN ; Zhong-Qi YANG ; Jun-Hua ZHANG ; Bao-He WANG ; Si-Yuan HU ; Zu-Guang YE ; Ling HAN ; Yue-Hua ZHOU ; Zi-Feng YANG ; Rui GAO ; Ming YANG ; Ting WANG ; Jie-Lai XIA ; Shi-Shan YU ; Xiao-Hui FAN ; Hua HUA ; Jia HE ; Yin LU ; Zhong WANG ; Jin-Hui DOU ; Geng LI ; Yu DONG ; Hao YU ; Li-Ping QU ; Jian-Yuan TANG
China Journal of Chinese Materia Medica 2025;50(12):3474-3482
Medical institutions, with their clinical practice foundation and abundant human use experience data, have become important carriers for the inheritance and innovation of traditional Chinese medicine(TCM) and the "cradles" of the preparation of new TCM. To effectively promote the transformation of new TCM originating from the TCM clinical practice in medical institutions and establish an effective evaluation index system for the transformation of new TCM conforming to the characteristics of TCM, consensus experts adopted the literature research, questionnaire survey, Delphi method, etc. By focusing on the policy and technical evaluation of new TCM originating from the TCM clinical practice in medical institutions, a comprehensive evaluation from the dimensions of drug safety, efficacy, feasibility, and characteristic advantages was conducted, thus forming a comprehensive evaluation system with four primary indicators and 37 secondary indicators. The expert consensus reached aims to encourage medical institutions at all levels to continuously improve the high-quality research and development and transformation of new TCM originating from the TCM clinical practice in medical institutions and targeted at clinical needs, so as to provide a decision-making basis for the preparation, selection, cultivation, and transformation of new TCM for medical institutions, improve the development efficiency of new TCM, and precisely respond to the public medication needs.
Medicine, Chinese Traditional/standards*
;
Humans
;
Consensus
;
Drugs, Chinese Herbal/therapeutic use*
;
Surveys and Questionnaires
7.Application value of gastric suspension method in supra-pancreatic lymph node dissection of laparoscopic radical gastrectomy of gastric cancer
Mengmeng LE ; Jingyang HE ; Siwei PAN ; Xiangliu CHEN ; Can HU ; Yanqiang ZHANG ; Jianfa YU ; Zhiyuan XU
Chinese Journal of Digestive Surgery 2025;24(3):389-393
Objective:To investigate the application value of gastric suspension method in supra-pancreatic lymph node dissection of laparoscopic radical gastrectomy of gastric cancer.Method:The retrospective cohort study was conducted. The clinicopathological data of 84 patients who under-went laparoscopic radical gastrectomy of gastric cancer at Zhejiang Cancer Hospital from August 2023 to July 2024 were collected. There were 61 males and 23 females, aged (64±11)years. Of the 84 patients, 42 patients undergoing supra-pancreatic lymph node dissection during laparoscopic radical gastrectomy of gastric cancer with traditional method for surgical field exposure were divided into the control group, and 42 patients undergoing supra-pancreatic lymph node dissection during laparoscopic radical gastrectomy of gastric cancer with gastric suspension method for surgical field exposure were divided into the suspension group. Observation indicators: (1) surgical conditions; (2) postoperative conditions. Comparison of measurement data with normal distribution between groups was conducted using the independent sample t test. Comparison of measurement data with skewed distribution between groups was conducted using the Mann-Whitney U test. Comparison of count data between groups was conducted using the chi-square test. Results:(1) Surgical condi-tions. The time for supra-pancreatic lymph node dissection of the control group was (78±14)minutes. Number of grasping operations was 116±34, number of bleeding sites caused by grasping operations was 7.8±2.7, and operation time was (3.9±0.8)hours. The above indicators of the suspension group were (59±12)minutes, 68±19, 2.1±1.5, and (3.3±0.7)hours, respectively. There were significant diffe-rences in the above indicators between the two groups ( t=5.42, 8.10, 8.31, 3.14, P<0.05). (2) Post-operative conditions. The tumor diameter was 2.5(2.0,3.5)cm for patients of the control group, versus 3.0(2.4, 4.4)cm for patients of the suspension group, showing a significant difference between the two groups ( Z=-1.98, P<0.05). Conclusion:Compared with the traditional non-suspension method, the gastric suspension method in laparoscopic radical gastrectomy of gastric cancer for supra-pancreatic lymph node dissection is associated with shorter operation time and less trauma.
8.Multi-Sequence MRI Radiomics for Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer with Brain Metastases
Zifeng DING ; Ruimin HE ; Dongyong SHAN ; Kun YU ; Chuangye HU
Chinese Journal of Medical Imaging 2025;33(11):1157-1163
Purpose To investigate the feasibility of multi-sequence MRI-based radiomics for predicting epidermal growth factor receptor(EGFR)mutation status in brain metastases from non-small cell lung cancer(NSCLC).Materials and Methods This retrospective study included 237 patients with NSCLC brain metastases from the Second Xiangya Hospital of Central South University(January 1,2017 to December 31,2023)who underwent EGFR genetic testing.All patients underwent pretreatment brain MRI including contrast-enhanced T1-weighted,T2-weighted FLAIR,and T2-weighted sequences,along with chest CT for primary lung lesions.EGFR mutations were identified in 120 patients.Using December 31,2021 as the cutoff date,patients were divided into training(n=146)and validation(n=91)cohorts.Senior radiologists delineated brain metastases on multi-sequence MRI and primary lesions on CT.A total of 851 radiomic features were extracted using PyRadiomics.Following feature selection,machine learning models were constructed using support vector machine algorithm and compared with least absolute shrinkage and selection operator-derived radiomic signatures.Five models were developed:three single-sequence MRI models,a multi-sequence MRI fusion model,and a CT model,with diagnostic performance evaluated by area under the receiver operating characteristic curve.Results The multi-sequence MRI fusion model demonstrated superior performance across all imaging types.The least absolute shrinkage and selection operator and support vector machine models achieved training set area under the curve of 0.854(95%CI 0.748-0.960)and 0.948(95%CI 0.923-0.973),respectively,and validation set area under the curve of 0.810(95%CI 0.751-0.869)and 0.951(95%CI 0.917-0.985),respectively.The optimal prediction model utilized support vector machine algorithm with multi-sequence MRI features.Conclusion Pretreatment multi-sequence MRI radiomics combined with machine learning accurately predicts EGFR mutation status in NSCLC patients with brain metastases.
9.Expert consensus on medical nutrition management and exercise intervention for patients with sarcopenia and concomitant chronic diseases (2024)
Junren KANG ; Mei WANG ; Jing ZHU ; Wen HU ; Cuifeng ZHU ; Mei HE ; Kang YU
Chinese Journal of Clinical Nutrition 2025;33(1):1-15
Sarcopenia, characterized by reduced muscle mass, decreased strength, and impaired function, can lead to adverse outcomes, such as frailty, falls, fractures and disability, and subsequently lead to decreased quality of life, increased risk of complications and mortality and elevated healthcare costs. With the accelerating process of global aging, the prevalence of sarcopenia has significantly risen, posing a major public health threat and socioeconomic burden to populations worldwide. To more effectively implement medical nutrition management and exercise intervention for patients with sarcopenia, the Chinese Clinical Nutritionist Center of Chinese Medical Doctor Association and the Nutrition Oncology Branch and Geriatric Nutrition Branch of the Chinese Nutrition Society, in collaboration with the Nutrition and Food Safety Branch of Chinese Geriatrics Society, have developed the Expert Consensus on Medical Nutrition Management and Exercise Intervention for Sarcopenia (2024) based on the latest research evidence, clinical practice experiences and clinical nutrition guidelines. This consensus serves as a reference for clinical diagnosis and treatment of sarcopenia. The consensus emphasizes that the diagnosis and treatment of sarcopenia should focus on elderly population and also encompass patients with related chronic diseases including diabetes, inflammatory bowel disease, cancer, cognitive dysfunction and Parkinson's disease. Multi-modal lifestyle interventions centered on nutrition and exercise remain the preferred strategy for the prevention and treatment of sarcopenia.
10.Expert consensus on medical nutrition management and exercise intervention for patients with sarcopenia and concomitant chronic diseases (2024)
Junren KANG ; Mei WANG ; Jing ZHU ; Wen HU ; Cuifeng ZHU ; Mei HE ; Kang YU
Chinese Journal of Clinical Nutrition 2025;33(1):1-15
Sarcopenia, characterized by reduced muscle mass, decreased strength, and impaired function, can lead to adverse outcomes, such as frailty, falls, fractures and disability, and subsequently lead to decreased quality of life, increased risk of complications and mortality and elevated healthcare costs. With the accelerating process of global aging, the prevalence of sarcopenia has significantly risen, posing a major public health threat and socioeconomic burden to populations worldwide. To more effectively implement medical nutrition management and exercise intervention for patients with sarcopenia, the Chinese Clinical Nutritionist Center of Chinese Medical Doctor Association and the Nutrition Oncology Branch and Geriatric Nutrition Branch of the Chinese Nutrition Society, in collaboration with the Nutrition and Food Safety Branch of Chinese Geriatrics Society, have developed the Expert Consensus on Medical Nutrition Management and Exercise Intervention for Sarcopenia (2024) based on the latest research evidence, clinical practice experiences and clinical nutrition guidelines. This consensus serves as a reference for clinical diagnosis and treatment of sarcopenia. The consensus emphasizes that the diagnosis and treatment of sarcopenia should focus on elderly population and also encompass patients with related chronic diseases including diabetes, inflammatory bowel disease, cancer, cognitive dysfunction and Parkinson's disease. Multi-modal lifestyle interventions centered on nutrition and exercise remain the preferred strategy for the prevention and treatment of sarcopenia.

Result Analysis
Print
Save
E-mail